Neoadjuvant Chemo Benefits Young Women with Triple-Negative Breast Cancer

Share it with your friends Like

Thanks! Share it with your friends!


A review of nearly 9,000 breast cancer patients found young women under the age of 35 years were more likely to have a complete pathological response to neoadjuvant chemotherapy than older women. This advantage in cPR rates — 24% in young women vs. 16% in older women — was driven largely by the impact on triple-negative breast cancer.

IMNG Medical Media reporter Michele Sullivan interviews Dr. Sibylle Loibl on findings presented at the 2012 San Antonio Breast Cancer Symposium. For more news from the meeting, visit


Write a comment